Used as a key intermediate in the synthesis of suvorexant, a dual orexin receptor antagonist prescribed for the treatment of insomnia. Its structure enables selective binding to orexin receptors, helping regulate wakefulness. Due to its specific substitution pattern, it contributes to the metabolic stability and blood-brain barrier penetration of the final drug substance. Widely utilized in pharmaceutical research and development for sleep disorder therapeutics.